跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
李 春辉
数学学院
h-index
988
引用
12
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2018
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(23)
相似学者
(0)
指纹图谱
深入其中 Chunhui Li 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Angiopoietin
10%
Antiangiogenic Therapy
8%
Antibacterial Activity
50%
Antiinfective Agent
16%
Apolipoprotein C3
20%
Bafilomycin A1
8%
Chloroquine
8%
Clinical Study
8%
Copolymer
8%
Crop
50%
Db/Db Mouse
10%
Disease Model
50%
Diseases
50%
Drug Development
10%
Drug Discovery
10%
Epidemic
10%
Erythropoietin
18%
Escherichia coli
8%
Eye Disease
8%
Ferric Hydroxide
8%
Hypoxia
8%
Immunologic Adjuvant
10%
Infection
50%
Lanthanide
50%
Malignant Neoplasm
50%
Messenger RNA
50%
Metabolic Disorder
10%
Micelle
50%
Mouse Model
8%
Nanocarrier
58%
Nanoparticle
50%
Non-Viral Vector
8%
Nucleic Acid
79%
Nucleic Acid Delivery
8%
Pandemic
10%
Polo Like Kinase 1
50%
Polycation
50%
Preclinical Study
8%
Programmed Death 1 Ligand 1
10%
Quaternary Ammonium Derivative
8%
Retina Neovascularization
50%
Skin Disease
12%
Small Interfering RNA
100%
Solid Lipid Nanoparticle
50%
Transgenic Mouse
10%
Tumor Model
7%
Urate Oxidase
50%
Uric Acid
25%
Zeta Potential
25%
Medicine and Dentistry
Angiopoietin
10%
Animal Testing
5%
Apolipoprotein B
6%
Apolipoprotein C3
20%
Cancer Cell
11%
Cancer Therapy
50%
Cancer Treatment
5%
Carbon
6%
Cas9
50%
Cell Line
11%
Cell Membrane
5%
Cell Proliferation
5%
Clustered Regularly Interspaced Short Palindromic Repeat
16%
Contact Examination
12%
CRISPR Cas System
16%
Cyclopeptide
5%
Disease
5%
Fetal Bovine Serum
12%
Gene Silencing
50%
Gene Targeting
6%
Genetic Transfection
6%
Growth Inhibition
16%
Hepatocellular Carcinoma
5%
In Vitro
5%
Infectious Disease Prevention
12%
Internalization
5%
Intravenous Drug Administration
16%
Luciferase
6%
Lysosome
5%
MRI Contrast Agent
5%
Nanocarrier
16%
Non Invasive Procedure
5%
Nucleic Acid
16%
Oncogene
16%
Pentetic Acid
5%
Photodynamic Therapy
16%
Photosensitizer
11%
Plasmid
16%
Polo Like Kinase 1
33%
Programmed Cell Death
5%
Reactive Oxygen Species
50%
RNA Interference
50%
RNAi Therapeutics
5%
Small Interfering RNA
50%
Transgenic Mouse
10%
Translational Medicine
5%
Treatment of Hyperlipidemia
50%
Tumor Progression
5%
Xenograft
21%
Biochemistry, Genetics and Molecular Biology
Angiopoietin
12%
Antiviral Activity
16%
Apolipoprotein B
6%
Apolipoprotein C3
25%
Bafilomycin
8%
Blood Group A Antigen
7%
Bovine Serum Albumin
5%
Cas9
25%
Contrast Medium
10%
Coronaviridae
16%
Coronavirinae
50%
CRISPR Cas System
12%
CRISPR/Cas9
12%
Cyclic Peptide
5%
Db/Db Mouse
12%
EC50
8%
Gene Targeting
6%
Gene Therapy
12%
Genome Editing
50%
Growth Inhibition
12%
Human Coronavirus 229E
8%
Human Coronavirus OC43
8%
Hydrophobicity
6%
Immunosurveillance
8%
Luciferase
6%
Mature Virus
7%
Murine
5%
Oncogene
12%
PD-L1
8%
Pegylated Lipid
5%
Plasmid
12%
Polo-Like Kinase
25%
Protein Adsorption
6%
RRM2
11%
SARS Coronavirus
50%
Small Interfering RNA
12%
Transgenic Mouse
12%
Triacylglycerol Blood Level
12%
Virus Nucleocapsid
50%
